Jeremy Szafron: Hello everyone and welcome to Investors Scene. Today on the show we are very excited to be introducing you to Jeffery Stevens. He is the CEO of Psyched Wellness, a company traded on the CSC. It’s an exciting space to be in, specifically because it’s wellness. Jeffery, welcome to the show. Jeffery Stevens: Thank you. It’s a pleasure to be here and I welcome the opportunity. Jeremy Szafron: We have seen a lot of psychedelic plays out there. This is a unique approach in that you have a legal mushroom product that has interesting compounds. Moreso, you have a unique team. For those in the audience who have not heard of Psyched Wellness, let’s talk a little bit about the company.Jeremy Szafron: It’s an interesting time. We are seeing states flipping over when it comes to psychedelics. As for the cannabis sector, we saw the destigmitatazion. This is a legal product and so you would think that the path to market is quicker here. Jeffery Stevens: Our peers who are doing the work on the clinical side and therapy side, they are doing great work with compounds like LSD. However, those are 3-5 years of studies and take time and money. We wanted to work with a compound that is legal. Amanita muscaria is legal and has never been classified as a drug. We are able to work with it and extract it and put it in the form of a tincture.
Vecima First to Complete Successful Multi-Tenancy Test with Streaming Video Technology Alliance Open Caching Testbed Initiative
2 mins ago
19 mins ago